Top 100 alternative sites to adaptimmune.com
-
medigene.com
-
tcr2.com
-
car-tcr-summit.com
-
cgoncology.com
-
formatherapeutics.com
-
vaccibody.com
-
bellicum.com
-
abcentra.com
-
atossatherapeutics.com
-
eurekatherapeutics.com
-
tessacell.com
-
imv-inc.com
-
blackthornrx.com
-
biolinerx.com
-
epizyme.com
-
akebia.com
-
cardiffoncology.com
-
ikenaoncology.com
-
zelluna.com
-
rapt.com
-
cellectis.com
-
chinooktx.com
-
iomx.com
-
mtem.com
-
connectbiopharm.com
-
newron.com
-
orphomed.com
-
abcuro.com
-
trevena.com
-
mersana.com
-
corvuspharma.com
-
desentum.fi
-
orca-therapeutics.nl
-
adicetbio.com
-
zymeworks.com
-
epirium.com
-
soricimed.com
-
geron.com
-
oysterpointrx.com
-
ampiopharma.com
-
zikani.com
-
ptxtherapeutics.com
-
ultimovacs.com
-
lineagecell.com
-
arcturusrx.com
-
precirix.com
-
kartosthera.com
-
oculis.com
-
cariboubio.com
-
athenex.com
-
lipocine.com
-
birchbiomed.com
-
personalis.com
-
i-mabbiopharma.com
-
erc-immunotherapy.com
-
litevax.com
-
akaalpharma.com
-
pharmacyte.com
-
quoruminnovations.com
-
oncternal.com
-
synimmune.de
-
clexio.com
-
harpoontx.com
-
onconova.com
-
bjeaglesky.com
-
ocugen.com
-
azurrx.com
-
kiorapharma.com
-
iksuda.com
-
polypid.com
-
immutep.com
-
sotio.com
-
mainstcapital.com
-
diamedica.com
-
brunswick.com
-
rigel.com
-
clsholdingsinc.com
-
cabalettabio.com
-
processapharmaceuticals.com
-
cytodyn.com
-
admabiologics.com
-
bristowgroup.com
-
callon.com
-
roth.com
-
codaoctopus.com
-
riotblockchain.com
-
bioxceltherapeutics.com
-
bgpgroup.ca
-
fortressbiotech.com
-
k3005.com
-
ltbridge.com
-
lucbro.com
-
matw.com
-
macysinc.com
-
provider.inogen.com
-
texaspacific.com
-
pieris.com
-
investors.coca-colacompany.com
-
newresi.com
-
heatbio.com
Medigene - Home
TCR² Therapeutics
TCR² is developing a new generation of T cell therapies for patients suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells harness the natural T cell receptor complex to recognize and **** cancer cells using the full power of T cell signaling pathways independent of HLA.
6th CAR-TCR Summit | Aug 30 - Sep 2, 2021 | Digital
The 6th CAR-TCR Summit 2021 is dedicated to the development of safe, clinically effective & globally accessible CAR & TCR based cell immunotherapies inoncology & beyond
Oncolytic immunotherapy | CG0070 | CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.
Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company focused on therapeutics to transform the lives of patients with rare hematologic diseases and cancers.
Home - Vaccibody.com
Vaccibody is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies
Home - Bellicum Pharmaceuticals, Inc. : Bellicum Pharmaceuticals, Inc.
Bellicum is a clinical stage company focused on developing novel cellular immunotherapies for certain cancers and orphan inherited blood disorders.
Abcentra - Therapeutics
Abcentra is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for cardiovascular and inflammatory diseases.
Atossa Therapeutics - A Clinical-Stage Biopharmaceutical Company
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on **** cancer treatment and other **** conditions.
Eureka Therapeutics | ARTEMIS™ | E-ALPHA® | T-cell therapies
Eureka Therapeutics, a clinical stage biopharmaceutical company with the goal of curing cancer by developing novel T-cell therapies that harness the evolutionary power of the immune system.
Tessa Therapeutics | Cancer Immunotherapy Treatments
Cure cancers with our innovative and widely accessible immunotherapies. Tessa Therapeutics is a clinical-stage biotechnology company focused on the development of autologous and allogeneic cell therapies for a broad range of cancers.
IMV Inc.
IMV Inc. is a clinical-stage biopharmaceutical company developing a new class of cancer immunotherapies and vaccines against infectious diseases
Neurobehavioral Disorder **** Development | BlackThorn Therapeutics
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company developing novel, targeted treatments for neurobehavioral disorders. Learn more.
Home | BioLineRx
BioLineRx is a clinical-stage biopharmaceutical company focused on oncology. The Company in-licenses novel compounds, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or commercialization.
Home - Epizyme
Epizyme is a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer
Home - Akebia Therapeutics
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Oncology Therapeutics - Cardiff Oncology
Cardiff Oncology is a clinical-stage company with the singular mission of developing new oncology therapeutic options for cancer patients.
Ikena Oncology | Biomarker-Driven Cancer Therapeutics
Ikena Oncology is a clinical-stage biotechnology company that discovers and develops patient-directed, biomarker-driven therapies for cancer patients.
Author: Walid
Zelluna Immunotherapy AS
Zelluna Immunotherapy AS is a privately owned biopharmaceutical company focused on the development of TCR based immunotherapies.
Other sites like adaptimmune com
Homepage - RAPT Therapeutics
RAPT Therapeutics is a clinical-stage biopharmaceutical company driven by a bold mission—to conquer cancer and inflammatory disease in our lifetime. Our cutting-edge science is fully focused on developing **** therapeutics that intelligently target key drivers of the immune system to transform the treatment of cancer and inflammation, and improve and empower countless lives. Join us …
Home | Cellectis
Cellectis is a clinical-stage biopharmaceutical company developing the Next-Generation CAR T-Cells to Cure Cancer
Chinook Therapeutics | Atrasentan
Chinook is a clinical-stage biopharmaceutical company discovering, developing and commercializing precision medicines for rare, severe chronic kidney diseases.
iOmx Therapeutics
We discover and develop next-generation targeted immunotherapy treatments for cancer patients. antibody, cancer, signaling cascades, shut-down, immune-break
Molecular Templates, Inc. (MTEM)
Molecular Templates is a clinical-stage biopharmaceutical company developing engineered toxin bodies (ETBs) for the treatment of cancers.
Connect Biopharma - Next-Generation Therapeutics for T Cell-Driven Inflammatory Diseases
Connect Biopharma is a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory diseases through the development of therapies derived from T cell-driven research.
Homepage | Newron Pharmaceuticals
We are a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system
OrphoMed Inc. | Gastrointestinal Disorders | Dimer Therapeutics Platform
OrphoMed is a clinical-stage biotechnology company with a proprietary dimer therapeutics platform. The company is focused on developing best-in class treatments for patients with gastrointestinal disorders.
Home - Abcuro
Development of immunotherapies for autoimmune diseases and cancer Read more about our approach in Fierce Biotech KLRG1 – A Compelling Clinical Target in Immune Modulation Abcuro is a clinical stage biotechnology company developing first-in-class immunotherapies for autoimmune diseases and cancer … Read More
Author: Abcuro
Trevena, Inc. (TRVN)
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous System conditions.
Mersana Therapeutics - Accelerating ADC Innovation …because patients are waiting.
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-**** conjugate (ADC) therapies to treat patients fighting cancer.
Bringing ingenuity to drugdevelopment
Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers.
Desentum
Desentum is a biopharmaceutical company developing novel types of allergen immunotherapy products (allergy vaccines) that actually change the way the immune system reacts to allergens.
Author: Super User
Home - ORCA Therapeutics
ORCA aims to significantly improve the lives of prostate cancer patients by developing safe and highly potent oncolytic virus immunotherapies.
Adicet Bio | Gamma Delta T cells
Adicet Bio, a pre-clinical stage biotechnology company engaged in the design and development of cutting-edge allogeneic immunotherapies for cancer and other diseases.
Zymeworks
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of cancer.
Epirium Bio
Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.
Soricimed : Home
Soricimed Biopharma is a clinical stage **** development company dedicated to novel trageted treatments for cancer.
Imetelstat | Myelofibrosis | Myelodysplastic Syndrome | Geron
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Oyster Point Pharma - Therapies to Address Ophthalmic Disease
We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease.
What else adaptimmune.com alternative websites
Ampio Pharmaceuticals
A development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options.
Zikani Therapeutics
Zikani Therapeutics is a preclinical-stage company developing and commercializing novel therapeutics that improve the lives of patients suffering from serious,life-threatening conditions.
Home - PTX Therapeutics
Prescient is an ASX-listed biotechnology company focused on improving outcomes for cancer patients by developing, licencing and collaborating on universal CAR-T therapies to treat a range of cancers.
Home - Ultimovacs
Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer. We enable the immune system to fight cancer
Home - Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
Arcturus Therapeutics
Arcturus Therapeutics is a clinical-stage messenger RNA medicines company focused on development and distribution of therapeutics for rare diseases & vaccines.
Precision radiopharmaceuticals | Precirix
PRECIRIX® is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments. The company is advancing its lead product CAM-H2 through a Phase I/II clinical trial targeting…
Home | Kartos Therapeutics
Kartos Therapeutics is a clinical stage biopharmaceutical company with an investigational MDM2 inhibitor, navtemadlin (KRT-232), KRT-232
Oculis |
Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back- and front-of-the-eye in order to improve the sight and the lives of patients worldwide.
Caribou Biosciences | Developing Sophisticated Allogeneic Cell Therapies
Caribou is a clinical-stage biopharmaceutical company focused on developing genome-edited allogeneic cell therapies for devastating human diseases.
Athenex
A global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer.
Home - Lipocine
IMPROVED **** ABSORPTION | BETTER PATIENT COMPLIANCE Improving Health We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine … Home Read More »
BirchBioMed | Anti-scarring | Auto-immune Therapeutics | Transplantation
A clinical-stage biomedical company focused on clinical evaluation, development and commercialization of anti-scarring drugs and autoimmune therapeutics.
Home - Personalis
Personalis Publishes New Data Demonstrating a Novel Composite Biomarker NEOPS™ for Predicting Response to Cancer Immunotherapy in Late-Stage Melanoma Patients The Personalis Mission To transform the development of next-generation cancer therapies by providing more comprehensive
Author: Mckinleymedia
I-Mab Biopharma | Bringing Transformational Medicines to Patients Through Innovation
I-Mab is a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class and best-in-class biologics to treat cancers and autoimmune diseases.
ERC - Epitopoietic Research Corporation
ERC is a clinical stage emerging Bio-pharmaceutical Company developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with Glioblastoma multiforme (GBM) the most deadliest form of brain cancer using its patented Gliovac/ERC1671 vaccine.
Author: Www Erc Eu
Welcome to LiteVax
LiteVax BV is a biopharmaceutical company focusing on the development and exploitation of novel adjuvant concepts.
Akaal Pharma Pty Ltd | clinical-stage **** discovery and development
Akaal Pharma is a clinical-stage **** discovery and development company focused on developing novel drugs for the treatment of inflammatory diseases.
PharmaCyte Biotech - Home of Biotechnology
PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes.
QUORUM INNOVATIONS | Microbiome & Biofilm Therapeutics
Quorum Innovations is a biopharmaceutical company focused on discovering and developing human microbiome therapeutics.
Other websites similar as adaptimmune.com
Oncternal Therapeutics | Home
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.
SYNIMMUNE GmbH: Welcome
SYNIMMUNE GmbH is a biotechnology company focusing on the development of novel mono- and bispecific antibodies for improved immunotherapy of.
Clexio Biosciences Ltd.
Clexio Biosciences is a CNS-first clinical stage company. We are dedicated to developing novel drugs and technologies for patients suffering.
Harpoon Therapeutics | Immuno-oncology | TriTAC™
Harpoon Therapeutics is an immuno-oncology company using a proprietary technology platform focused on T cell engagement to discover and develop novel biologics for the treatment of cancer and other diseases.
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Onconova Therapeutics, Inc. is focused on discovering and developing novel small molecule **** candidates to treat cancer.
Bepotastine besylate|Febuxostat|Eagle Sky PharmaTech
Eagle Sky PharmaTech is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs. The company has developed an...
Ocugen, Inc. – Pursuing Innovative Ocular Biotherapeutics
Ocugen, Inc. is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases.
AzurRx BioPharma
AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. Our therapeutic products will be administered to patients as **** non-systemic biologics.
EyeGate Pharma Announces Transformative Acquisition of Panoptes Pharma - Kiora Pharmaceuticals
WALTHAM, MA, December 21, 2020 (ACCESSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”), a clinical stage company focused on developing products for treating disorders of the eye, today announced the acquisition of Panoptes Pharma (“Panoptes”), a privately-held clinical stage biotech company focused on developing a novel proprietary small molecule for the treatment […]
Author: Kioradev
We build superior ADCs | Iksuda Therapeutics
Iksuda is an emerging biotechnology company focused on developing antibody-based therapies for the treatment of cancer as well as broader based therapeutics. Our main goal is to develop effective therapies to improve patients’ lives. Our mission is to enable improved clinical regimes through cre ...
Author: Base Creative
PolyPid - Optimized Therapeutics
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
LAG-3 - Effective Cancer Immunotherapy | Immutep
Immutep is a leading biotechnology company focused on developing effective autoimmune and cancer immunotherapy treatments such as Lag-3.
SOTIO®
SOTIO is developing the next generation of potent immunotherapies for patients with cancer.
Author: ANDWEB s.r.o
Some websites with similar theme to adaptimmune.com include:
Main Street Capital Corporation (MAIN)
DiaMedica Therapeutics, Inc. (DMAC)
DiaMedica Therapeutics is a biopharmaceutical company that specializes in creating synthetic proteins to treat a variety of conditions.
Brunswick Corporation
Brunswick Corporation, a world-class leader in the marine industry, turns innovation into reality via renowned marine brands.
Rigel Pharmaceuticals, Inc. (RIGL)
CLS Holdings USA, Inc. (CLSH)
Cannabis Life Sciences is both a cannabis producer and retailer offering a wide variety of products through its brands, Oasis and City Trees.
Cabaletta Bio, Inc.
Cabaletta Bio discovers and develops targeted cell therapy product candidates to potentially cure patients with autoimmune diseases. Learn about our CAAR T cell products.
Processa Pharmaceuticals, Inc. (PCSA)
Processa Pharmaceuticals is committed to developing **** products aimed at improving the quality of life for patients with unmet medical needs.
More other alternatives for adaptimmune com
CytoDyn Inc.
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
ADMA Biologics, Inc. (ADMA)
Bristow Group Inc. (VTOL)
Bristow provides safe, reliable and efficient helicopter services for offshore oil and gas transportation, SAR and government and civil organizations.
Callon Petroleum Company
Callon Petroleum Company is an independent oil and natural gas company focused on the acquisition, exploration and development of high-quality assets in the heart of the Permian Basin.
ROTH Capital Partners, LLC
ROTH Capital Partners, LLC is a relationship-driven investment bank focused on serving emerging growth companies and their investors.
Coda Octopus Products Ltd.
Coda Octopus is a global leader and specialist in underwater technologies. We design and manufacture innovative and patented real-time 3D sonar solutions and other leading products for sale to the subsea, defense, mining and marine sciences markets, among
Riot Blockchain, Inc. (RIOT)
BioXcel Therapeutics, Inc. (BTAI)
BioXcel Therapeutics is developing high value therapeutics in neuroscience and immuno-oncology utilizing a novel artificial intelligence platform.
BGP Environmental Group
Fortress Biotech, Inc. (FBIO)
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that was ranked in Deloitte’s 2019 and 2020 Technology Fast 500™, annual rankings of the fastest-growing North American companies in the technology,…
幸运飞艇最新开奖结果查询-实时开奖直播视频-新版飞鹰计划 Norwegian Cruise Line Holdings Ltd. (NCLH)
Lightbridge Corporation (LTBR)
Lightbridge Corporation is a nuclear fuel technology development company focused on addressing the world’s climate and energy needs.
Lucosky Brookman LLP
Lucosky Brookman is a corporate finance and securities law firm directly serving select clientele in the small and middle markets.
Matthews International Corporation (MATW)
Matthews International Corporation is a global provider of brand solutions, memorialization products and industrial technologies.
Macy's, Inc.
Macy’s, Inc. is one of the nation’s premier omnichannel retailers. Headquartered in New York City, the company comprises three retail brands: Macy’s, Bloomingdale’s and Bluemercury. With a robust e-commerce business, rich mobile experience and a national stores footprint, our customers can shop the way they live — anytime and through any channel.
Inogen, Inc
Learn how Inogen, leaders for the best portable oxygen concentrators, can help HME providers! Leading the way in the development of portable oxygen technology.
Texas Pacific Land Corporation (TPL)
Texas Pacific Land Trust is one of the largest landowners in the State of Texas with approximately 900,000 acres of land in West Texas.
Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals is committed to the discovery and development of Anticalin®-based drugs that target validated disease pathways.
Investor Relations :: The Coca-Cola Company (KO)
New Residential Investment Corp. (NRZ)
New Residential is a publicly traded mortgage real estate investment trust with a diversified portfolio and a strong track record of performance.
Activating the Immune System :: Heat Biologics, Inc. (HTBX)
At Heat Biologics, our drugs are designed to take advantage of a natural biological process to robustly activate and stimulate T-cells to turn COLD tumors HOT.
